Polymer-based biodegradable drug delivery systems in pain management

Journal of Craniofacial Surgery

Volumn 17, Issue 2, 2006, Pages 302-313

  Al Malyan, Mohamed ^a   Becchi, Chiara ^a   Nikkola, Lila ^b   Viitanen, Petrus ^b   Boncinelli, Sergio ^a   Chiellini, Federica ^c   Ashammakhi, Nureddin ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Biodegradable polymers; Controlled drug delivery; Nanomat; Pain

Indexed keywords

3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; BETAMETHASONE; BUPIVACAINE; BUTYLCAINE; CINCHOCAINE; COPOLYMER; DEXAMETHASONE; DICLOFENAC; ETIDOCAINE; FELBINAC; INDOMETACIN; KETOPROFEN; LIDOCAINE; LOCAL ANESTHETIC AGENT; MECLOFENAMIC ACID; MEPIVACAINE; MICROSPHERE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; POLY(ORTHO ESTER); POLYANHYDRIDE; POLYESTER; POLYGLACTIN; POLYLACTIC ACID; POLYMER; PRILOCAINE; SILASTIC; TETRACAINE; UNINDEXED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIODEGRADABILITY; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DEVICE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; MOLECULAR WEIGHT; NANOTECHNOLOGY; NEUROPATHIC PAIN; NONHUMAN; PAIN; PHYSICAL CHEMISTRY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; UNSPECIFIED SIDE EFFECT;

ABSORBABLE IMPLANTS; ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; MICROSPHERES; PAIN; POLYGLYCOLIC ACID; POLYMERS;

EID: 33748252254     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001665-200603000-00018     Document Type: Article

References (204)

1. International Association for the Study of Pain. IASP Pain Terminology [IASP Website]. November 9, 2004. Available at: http://www.iasp-pain.org/terms- p.html. Accessed September 24, 2004
2. Brower V. New paths to pain relief. Nat Biotechnol 2000;18:387-391
3. Gureje O, Von Korff M, Simon GE, et al. Persistent pain and well-being: a World Health Organization study in primary care. JAMA 1998;280:147-151
4. Loeser JD, Butler SH, Chapman CR, et al, eds. Bonica's Management of Pain. 3rd Ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001
5. Parrott T. Pain management in primary-care medical practice. In: Tollison CDSatterthwaithe JRTollison JW, eds. Practical Pain Management, 3rd Ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:729-759
6. Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med 1998;105:45S-52S
7. Roper Starch Worldwide Inc. (Telephone Survey). Chronic pain in America: roadblocks to relief. Survey highlights [American Pain Society website] February 19, 1999. Available at: http://www.ampainsoc.org/whatsnew/toc_road.htm#toc. Accessed September 24, 2004
8. Zimmerman M. Chronic pain. Epidemiology and management in Germany. Orthopade 2004;33:508-514
9. Loeser JD. Pain: an overview. Lancet 1999;353:1607-1609
10. McCleskey EW, Gold MS. Ionchannels of nociception. Annu Rev Physiol 1999;61:835-856
11. Olsson Y. Microenvironment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol 1990;5:265-311
12. Maves TJ, Gebhart GF, Meller ST. Continuous infusion of acidified saline around the rat sciatic nerve produces thermal hyperalgesia. Neurosci Lett 1995;194:45-48
13. Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett 1994;165:71-74
14. Bevan SJ, Geppetti P. Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends in Neuroscience 1994;17:509-512
15. Dray A. Tasting the inflammatory soup: role of peripheral neurons. Pain Reviews 1994;1:153-171
16. Coleman RA, Smith WL, Narurniya S. Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacological Reviews 1994;46:205-229
17. Regan JM, Peng P. Neurophysiology of cancer pain. Cancer Control 2000;7:111-119
18. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000;288:1765-1769
19. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000;51:29-57
20. Dray A. Inflammatorymediators of pain. Br J Anaesth 1995;75:125-131
21. Simone DA, Alreja M, LaMotte RH. Psychophysical studies of the itch sensation and itchy skin ("allokinesis") produced by intracutaneous injection of histamine. Somatosens Mot Res 1991;8:271-279
22. Liu T, Knight KR, Tracey DJ. Hyperalgesia due to nerve injury-role of peroxynitrite. Neuroscience 2000;97:125-131
23. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003;5:1-16
24. Davis AJ, Perkins MN. The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br J Pharmacol 1994;113:63-68
25. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992;49:693-698
26. Le Corre P, Estebe JP, Chevanne F, et al. Spinal controlled delivery of bupivacaine from DL-lactic acid oligomer microspheres. J Pharm Sci 1995;84(1):75-78
27. Birrell GJ, McQueen DS, Iggo A, et al. PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett 1991;124:5-8
28. Minke B, Cook B. TRP channel proteins and signal transduction. Physiol Rev 2002;82:429-472
29. Woolf CJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Available at: http://www.fda.gov/ohrms/dockets/ac/02/slides/15. Accessed September 3, 2004
30. Carlton SM, Coggeshall RE. Nociceptive integration: does it have a peripheral component? Pain Forum 1998;7:71-78
31. Twycross R. Cancer pain classification. Acta Anaesthesiol Scand 1997;41:141-145
32. Adami S. Bisphosphonatesin prostate carcinoma. Cancer 1997;80:1674-1679
33. McMahon SB, Koltzenberg M. Silent afferents and visceral pain. In: Fields HL, Liebeskind JC, eds. Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Progress in Pain Research and Management. Vol 1. Seattle: IASPPress; 1994:11-30
34. Fink D, Mata M, Glorioso JC. Cell and gene therapy in the treatment of pain. Adv Drug Deliv Rev 2003;55(8):1055-1064
35. Devor M, Govrin-Lippmann R. Axoplasmic transport block reduces ectopic impulse generation in injured peripheral nerves. Pain 1983;16:73-85
36. Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neuronal discharge in experimental neuromas. Pain 1985;22:127-137
37. Devor M, Wall PD. Cross-excitation in dorsal root ganglia of nerve-injured and intact rats. J Neurophysiol 1990;64:1733-1746
38. England JD, Gamboni F, Levinson SR. Increased numbers of sodium channels form along demyelinated axons. Brain Research 1991;548:334-337
39. Yaksh TL, Chaplan SR. Physiology and pharmacology of neuropathicpain. Anesthesiol Clin North America 1997;15(2):335-352
40. Allen R. Neuropathic pain: mechanisms and clinical assessment. Assessment and treatment of cancer pain. Progress in Pain Research and Management 1998;12:159-173
41. Fields HL. Pain. NewYork: McGraw-Hill; 1987
42. Tasker RR. Central pain syndromes. In: Warfield CA, ed. Principles and Practice of Pain Management. NewYork: McGraw Hill, Inc; 1993:433-457
43. Pockett S. Spinal cord synaptic plasticity and chronic pain. Anesth Analg 1995;80:173-179
44. Scholz J, Woolf CJ. Can we conquer pain? Nat Neurosci 2002;5(Suppl):1062-1067
45. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001;413:203-210
46. Woolf CJ, American College of Physicians, American Physiological Society. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-451
47. Sugimoto T, Bennett GJ, Kajander KC. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection and strychnine. Pain 1990;42:205-213
48. Cameron AA, Cliffer KD, Dougherty PM, et al. Changes in lectin, GAP-43 and neuropeptide staining in the rat superficial dorsal horn following experimental peripheral neuropathy. Neurosci Lett 1991;131:249-252
49. Johnson BW, Parris WCV. Mechanisms of neuropathic pain. In: Raj PP, ed. Current Review of Pain, Current Medicine, 1994
50. Le Corre P, Le Guevello P, Gajan V, et al. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-coglycolide microspheres. Int J Pharm 1994;107:41-49
51. Meyer RA, Campbell JN, Raja SN. Peripheral and neural mechanisms of nociception. In: Wall PD, Melzack R, Bonica JJ, eds. Textbook of Pain, 3rd ed. Edinburgh: Churchill Livingstone; 1994:28-39
52. Thompson S. Plasticity of somatosensory pathways. Available at: http://www.kcl.ac.uk/depsta/biomedical/physiology/JP0392/ JP0392%20lecture%20plasticity%20of%20somatosensory%20pathways.pdf. Accessed September 24, 2004
53. Muir WW 3rd, Woolf CJ. Mechanisms of pain and their therapeutic implications. J Am Vet Med Assoc 2001;219(10):1346-1356
54. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120
55. Woodburn SE. Postoperativepain management. Clin Podiatr Med Surg 1994;11(1):55-64
56. Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 2001;95:241-249
57. Basbaum AI. Spinal mechanisms of acute and persistent pain. Reg Anesth Pain Med 1999;24(1):59-67
58. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;410:471-475
59. Wells C, Nown G. The Pain Relief Handbook. Buffalo, New York: Firefly Books Inc; 1998
60. Cross SA. Pathophysiology of pain. Mayo Clin Proc 1994;69:375-383
61. Eccleston C. Role of psychology in pain management. Br J Anaesth 2001;87(1):144-152
62. Katz N. The impact of pain management on quality of life. J Pain Symptom Manage 2002;24(1 Suppl):S38-S47
63. Stucky CL, Gold Michael S, Xu Z. Mechanisms of pain 2000. Proc Natl Acad Sci U S A 2001;98(21):11845-11846
64. Engoren M. Cost-effectiveness of different postoperative analgesic treatments. ExpertOpin Pharmacother 2003;4(9):1507-1519
65. Renck H, Wallin R. Slow release formulations of local anesthetics and opioids. Current Opinion in Anesthesiology 1996;9:399-403
66. Garvin KL, Miyano JA, Robinson D, et al. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. JBone Joint Surg Am 1994;76:1500-1506
67. Fujita T, Tamura T, Yamada H, et al. Pharmacokinetic of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice. J Drug Target 1997;4:289-296
68. Labhasetwar V, Underwood T, Gallager M, et al. Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects. J Pharm Sci 1994;83:156-164
69. Reinhard CS, Radomsky ML, Saltzman WM, et al. Polymeric controlled release of dexamethasone in normal rat-brain. J Control Release 1991;16:331-340
70. Moo-Young AJ, Kuzuma P, Quandt H, et al. Clinical response to a 12 month histrelin hydrogel implant for the treatment of prostate cancer. Proc Int Symp Control Rel Bioact Mater 1998;25:64-65
71. Lesser GJ, Grossman SA, Leong KW, et al. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain 1996;65(2-3):265-272
72. Suhonen P, Jarvinen T, Lehmussaari K, et al. Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop. Pharm Res 1995;12(4):529-533
73. Ikeda R, Pelton C. Diversion programs for impaired physicians. West J Med 1990;152:617-621
74. Grant SA. The Holy Grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol 2002;16(2):345-352
75. Maszczynska Bonney I, Sendil Keskin D, Lipkowski AW, et al. Advances in analgesic drug design and delivery: a current survey. Adv Exp Med Biol 2004;553:209-219
76. Nikkola L, Vapalahti K, SeppäläJ, et al. Multifunctional nano structured DS releasing sheet. Presented at the Second World Congress on Synthetic Receptors (WCRM2005), Salzburg, Austria, September 7-9, 2005
77. Törmälä P. Biodegradable self-reinforced composite materials; manufacturing structure and mechanical properties. Clin Mater 1992;10:29-34
78. Törmälä P, Pohjonen T, Rokkanen P. Bioabsorbable polymers: materials technology and surgical applications. Proc Inst Mech Eng [H] 1998;212(2):101-111
79. Ashammakhi N, Rokkanen P. Absorbable polyglycolide devices in trauma and bone surgery. Biomaterials 1997;18:3-9
80. Ashammakhi N, Peltoniemi H, Waris E, et al. Developments in craniomaxillofacial surgery: use of self-reinforced bioabsorbable osteofixation devices. PlastReconstr Surg 2001;108(1):167-180
81. Ashammakhi N, Moreira A, Gonzalez AM, et al. Review: new resorbable bone fixation biomaterials in craniomaxillofacial surgery: present and future. EurJ Plast Surg 2004;26(8):383-390
82. Ashammakhi N, Suuronen R, Tiainen J, et al. Spotlight on naturally absorbable osteofixation devices. J Craniofac Surg 2003;14(2):247-259
83. Niemelä S-M, Ikäheimo I, Koskela M, et al. Ciprofloxacin- releasing bioabsorbable polymer is superior to titanium in preventing Staphylococcus epidermis attachment and biofilm formation in vitro. J Biomed Mater Res [Appl Biomat] (in press)
84. Tiainen J, Veiranto M, Suokas E, et al. Bioabsorbable ciprofloxacin-containing and plain self-reinforced polylactide-polyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. J Craniofac Surg 2002;13(3):427-433
85. Viitanen P, Suokas E, Törmälä P, et al. Release of diclofenac sodium from polylactide-go-glycolide 80/20 rods. J Mater Sci Mater Med (submitted)
86. St. Pierre T, Chiellini E. Biodegradability of synthetic polymers used for medical and pharmaceutical applications. Part 1 - principles of hydrolysis mechanism. J Bioact Compat 1986;1:467
87. St. Pierre T, Chiellini E. Biodegradability of synthetic polymers used for medical and pharmaceutical applications. Part 2 - backbone hydrolysis. J Bioact Compat 1987;2:4
88. St. Pierre T, Chiellini E. Biodegradability of synthetic polymers used for medical and pharmaceutical applications. Part 2 - pendent group hydrolysis. J Bioact Compat 1987;2:238
89. Chiellini E, Solaro R. Biodegradable polymeric materials. Adv Mat 1996;3:305
90. Chiellini E, Chiellini EE, Chiellini F, et al. Design of polymeric systems for targeted administration of peptide and protein drugs. In: Ottenbrite RM, Kim SW, eds. Polymeric Drugs and Drug Delivery Systems. Lancaster, PA: Technomic Publ; 2001:57
91. Chiellini E, Bizzarri R, Chiellini F. Chemical modification of natural and synthtetic polyesters. In: Biopolymers, Vol. 4 - Polyesters III (Part B). Germany: Wiley-VCHVerlag GmbH; 2001:329-374
92. Gopferich A, Tessmar J. Polyanhydride degradation and erosion. Adv Drug Deliv Rev 2002;54:911-931
93. Sendil D, Wise DL, Hasirci V. Assessment of biodegradable controlled release rod systems for pain relief applications. J Biomater Sci Polym Ed 2002;13(1):1-15
94. Li S, Vert M. Biodegradable polymers: polyesters. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. New York: Wiley; 1999:71-93
95. Winzenburg G, Schmidt C, Fuchs S, et al. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Adv Drug Deliv Rev 2004;56:1453-1466
96. Vert M. Aliphatic polyesters: great degradable polymers that cannot do everything. Biomacromolecules 2005;6:538-546
97. Heller J, Barr J, Ng SY, et al. Poly(ortho esters) - their development and some recent applications. Eur J Pharm Biopharm 2000;50:121-128
98. Heller J, Barr J. Poly (ortho esters) - from concept to reality. Biomacromolecules 2004;5(5):1625-1632
99. Heller J, Barr J, Ng S, et al. Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery. J Control Release 2002;78(1-3):133-141
100. Goeferich A. Biodegradable polymers: polyanhydride. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. NewYork: Wiley; 1999:45-73
101. Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics. Chem Pharm Bull (Tokyo) 1981;29(11):3363-3368
102. Wakiyama N, Juni K, Nakano M. Duration of the local anesthetic effect of tetracaine hydrochloride solutions and tetracaine in microspheres. J Pharmacobiodyn 1982;5:13-17
103. Wakiyama N, Juni K, Nakano M. Influence of physiochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics. Chem Pharm Bull (Tokyo) 1982;30(7):2621-2628
104. Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine. Chem Pharm Bull (Tokyo) 1982;30(10):3719-3727
105. Kojima T, Nakano M, Juni K, et al. Preparation and evaluation in vitro of polycarbonate microspheres containing local anesthetics. Chem Pharm Bull (Tokyo) 1984;32(7):2795-2802
106. Kojima T, Nakano M, Juni K, et al. Preparation and evaluation in vitro and in vivo of polycarbonate microspheres containing dibucaine. Chem Pharm Bull (Tokyo) 1985;33(11):5119-5125
107. Masters DB, Berde CB, Ward JM, et al. Biochemical and histologic effects of prolonged sciatic nerve blockade with bupivacaine using a biodegradable polymer matrix. (Abstract). Anesthesiology 1991;75(3A):A680
108. Masters DB, Berde CB, Dutta S, et al. Prolonged sciatic nerve blockade using sustained release of bupivacaine from a biodegradable polymer matrix. (Abstract). Anesthesiology 1991;75(3A):A765
109. Masters DB, Berde CB, Dutta SK, et al. Prolonged regional nerve blockade by controlled release of local anesthetic from a biodegradable polymer matrix.Anesthesiology 1993a;79:340-346
110. Masters DB, Berde CB, Dutta S, et al. Sustained local anesthetic release from bioerodible polymer matrices: a potential method for prolonged regional anesthesia. Pharm Res 1993;10(10):1527-1532
111. Peplow PV, Hurst PR. Characteristic of indomethacine and naproxen release from silastic polymeric rods in vitro. Prostaglandins Med 1981;6:29-39
112. Peplow PV. Identification of two different rate-limiting mechanisms controlling the release of NSAIDs from silastic polymeric devices, and possible implications. Prostaglandins Leukot Essent Fatty Acids 1993;48(5):391-395
113. Barr J, Woodburn KW, Ng SY, et al. Post surgical pain management with poly(ortho esters). Adv Drug Deliv Rev 2002;54(7):1041-1048
114. Deng JS, Li L, Tian Y, et al. In vitro characterization of polyorthoester microparticles containing bupivacaine. Pharm Dev Technol 2003;8(1):31-38
115. Le Corre P, Rytting JH, Gajan V, et al. In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co- glycolide) microspheres. J Microencapsul 1997;14(2):243-255
116. Le Corre P, Estebe JP, Clement R, et al. Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. Int J Pharm 2002;238(1-2):191-203
117. Estebe JP, LeCorre P, Malledant Y, et al. Prolongation of spinal anesthesia with bupivacaine-loaded (DL-lactide) microspheres. Anesth Analg 1995;81(1):99-103
118. Estebe JP, LeCorre P, Chevanne F, et al. Motor blockade by brachial plexus block in the sheep. Anesthesiology 2000;93(1):291-293
119. Estebe JP, LeCorre P, Du Plessis L, et al. The pharmacokinetics and pharmacodynamics of bupivacaine-loaded microspheres on a brachial plexus block model in sheep. Anesth Analg 2001;93(2):447-455
120. Estebe JP, Ecoffey C, Dollo G, et al. Bupivacaine pharmacokinetics and motor blockade following epidural administration of the bupivacaine- sulphobutylether 7-beta-cyclodextrin complex in sheep. Eur J Anaesthesiol 2002;19(4):308-310
121. Estebe JP, Gentili ME, Le Corre P, et al. Sciatic nerve block with bupivacaine-loaded microspheres prevents hyperalgesia in an inflammatory animal model. Can J Anaesth 2002;49(7):690-693
122. Estebe JP, LeCorre P, Clement R, et al. Effect of dexamethasone on motor brachial plexus block with bupivacaine and with bupivacaine-loaded microspheres in a sheep model. Eur J Anaesthesiol 2003;20(4):305-310
123. Malinovsky JM, Bernard JM, LeCorre P, et al. Motorand blood pressure effects of epidural sustained-release bupivacaine from polymer microspheres: a dose-response study in rabbits. Anesth Analg 1995;81:519-524
124. Curley J, Castillo J, Hotz J, et al. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996;84(6):1401-1410
125. Chandrashekar G, Udupa N. Biodegradable injectable implant systems for long term drug delivery using poly (lactic-coglycolic) acid copolymers. J Pharm Pharmacol 1996;48(7):669-674
126. Castillo J, Curley J, Hotz J, et al. Glucocorticoids prolong rat sciatic nerve blockade in vivo from bupivacaine microspheres. Anesthesiology 1996;85(5):1157-1166
127. Fletcher D, LeCorre P, Guilbaud G, et al. Antinociceptive effect of bupivacaine encapsulated in poly(D,L)-lactide-coglycolide microspheres in the acute inflammatory pain model of carrageenin-injected rats. Anesth Analg 1997;84(1):90-94
128. Drager C, Benziger D, Gao F, et al. Prolonged intercostal nerve blockade in sheep using controlled-release of bupivacaine and dexamethasone from polymer microspheres. Anesthesiology 1998;89(4):969-979
129. Castelli F, Conti B, Maccarrone DE, et al. Comparative study of "in vitro" release of antiinflammatory drugs from polylactide-co-glycolide. Int J Pharm 1998;176(1):85-98
130. Gabor F, Ertl B, Wirth M, et al. Ketoprofen-poly(D,L-lactic-coglycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics. J Microencapsul 1999;16(1):1-12
131. Gorner T, Gref R, Michenot D, et al. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release 1999;57(3):259-268
132. Blanco MD, Bernardo MV, Gomez C, et al. Bupivacaine-loaded comatrix formed by albumin microspheres included in a poly(lactide-co-glycolide) film: in vivo biocompatibility and drug release studies. Biomaterials 1999;20:1919-1924
133. Polakovic M, Gorner T, Gref R, et al. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release 1999;60(2-3):169-177
134. Ramirez L, Pastoriza P, Herrero-Vanrell R. Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In vitro release profile. J Microencapsul 1999;16(1):105-115
135. Garry MG, Jackson DL, Geier HE, et al. Evaluation of the efficacy of a bioerodible bupivacaine polymer system on antinociception and inflammatory mediator release. Pain 1999;82(1):49-55
136. Tunçay M, Calis S, Kas HS, et al. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 2000;195:179-188
137. Tunçay M, Calis S, Kas HS, et al. In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres. J Microencapsul 2000;17(2):145-155
138. Lin SY, Chen KS, Teng HH, et al. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. J Microencapsul 2000;17(5):577-586
139. Guterres SS, Fessi H, Barratt G, et al. Poly(rac-lactide) nanocapsules containing diclofenac: protection against muscular damage in rats. J Biomater Sci Polym Ed 2000;11(12):1347-1355
140. Bernardo MV, Blanco MD, Gomez C, et al. In vitro controlled release of bupivacaine from albumin microspheres and a comatrix formed by microspheres in a poly(lactide-co-glycolide) film. J Microencapsul 2000;17(6):721-731
141. Chung TW, Huang YY, Liu YZ. Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres. Int J Pharm 2001;16(212(2)):161-169
142. Horisawa E, Hirota T, Kawazoe S, et al. Prolonged antiinflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res 2002;19(4):403-410
143. Eniola AO, Rodgers SD, Hammer DA. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials 2002;23(10):2167-2177
144. Choi HS, Seo SA, Khang G, et al. Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. Int J Pharm 2002;234(1-2):195-203
145. Hickey T, Kreutzer D, Burgess DJ, et al. Dexamethasone/PLGA microspheres for continuous delivery of an antiinflammatory drug for implantable medical devices. Biomaterials 2002;23(7):1649-1656
146. Sendil-Keskin D, Altunay H, Wise DL, et al. In vivo pain relief effectiveness of an analgesic-anesthetic carrying biodegradable controlled release rod systems. J Biomater Sci Polym Ed 2003;14(6):497-514
147. Sendil D, Bonney IM, Carr DB, et al. Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats. Biomaterials 2003;24(11):1969-1976
148. Seo SA, Choi HS, Khang G, et al. A local delivery system for fentanyl based on biodegradable poly(L-lactide-co-glycolide) oligomer. Int J Pharm 2002;239(1-2):93-101
149. Seo SA, Khang G, Rhee JM, et al. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres. J Microencapsul 2003;20(5):569-579
150. Suter MR, Papaloizos M, Berde CB, et al. Development of neuropathic pain in the rat spared nerve injury model is not prevented by a peripheral nerve block. Anesthesiology 2003;99(6):1402-1408
151. Hasirci V, Bonney I, Goudas LC, et al. Antihyperalgesic effect of simultaneously released hydromorphone and bupivacaine from polymer fibers in the rat chronic constriction injury model. Life Sci 2003;73(26):3323-3337
152. Covino BG. Local anesthetics. In: Ferrante FM, VadeBoncourer TR, eds. Postoperative Pain Management. New York: Churchill Livingstone; 1993:211-253
153. White JL, Durieux ME. Clinical pharmacology of local anesthetics. Anesthesiol Clin North America 2005;23:73-84
154. Kawamata M, Takahashi T, Kozuka Y, et al. Experimental incision-induced pain in humanskin: effects of systemic lidocaine on flare formation and hyperalgesia. Pain 2002;100:77-89
155. Freville JC, Dollo G, LeCorre P, et al. Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex. Pharm Res 1996;13(10):1576-1580
156. Blanco MD, Bernardo MV, Sastre RL, et al. Preparation of bupivacaine-loaded poly(epsilon-caprolactone) microspheres by spray drying: drug release studies and biocompatibility. Eur J Pharm Biopharm 2003;55:229-236
157. Dollo G, Le Corre P, Freville JC, et al. Biopharmaceutics of local anesthetic-cyclodextrin complexes following loco-regional administration. Ann Pharm Fr 2000;58(6):425-432
158. Sendil KD, Wise DL, Hasirci V. Pain control via opioid analgesic - local anesthetic loaded IPNs. Current Drug Delivery 2004;1(1):57-64
159. Lubach JW, Padden BE, Winslow SL, et al. Solid-state NMR studies of pharmaceutical solids in polymer matrices. Anal Bioanal Chem 2004;378(6):1504-1510
160. Sato S, Baba Y, Tajima K, et al. Prolongation of epidural anesthesia in the rabbit with the use of a biodegradable copolymer paste containing lidocaine. Anesth Analg 1995;80(1):97-101
161. Doherty MM, Hughes PJ, Korszniak NV, et al. Prolongation of lidocaine-induced epidural anesthesia by medium molecular weight hyaluronic acid formulations: pharmacodynamic and pharmacokinetic studies in the rabbit. Anesth Analg 1995;80:740-746
162. Danjo K, Higuchi F, Otsuka A. Release of lidocaine from polymer film dosage forms. Chem Pharm Bull (Tokyo) 1995;43(10):1759-1763
163. Paavola A, Yliruusi J, Kajimoto Y, et al. Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res 1995;12(12):1997-2002
164. Paavola A, Yliruusi J, Rosenberg P. Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels. J Control Release 1998;52(1-2):169-178
165. Sahota TS, Latham RJ, Linford RG, et al. In vitro iontophoretic release of lithium chloride and lidocaine hydrochloride from polymer electrolytes. Drug Dev Ind Pharm 2000;26(10):1039-1044
166. Carlsson F, Elofsson U, Arnebrant T, et al. Interactions between local anaesthetic agents and poly(N-isopropyl acrylamide) through phase behavior, surface tension, and adsorption measurement. J Colloid Interface Sci 2001;233(2):320-328
167. Nurkeeva ZS, Mun GA, Khutoryanskiy VV, et al. Polymeric complexes of lidocaine hydrochloride with poly(acrylic acid) and poly(2-hydroxyethyl vinyl ether). J Biomater Sci Polym Ed 2002;13(7):759-768
168. Ricci EJ, Bentley MV, Farah M, et al. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci 2002;17(3):161-167
169. Ricci EJ, Lunardi LO, Nanclares DM, et al. Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm 2005;288:235-244
170. Sankar C, Rani M, Srivastava AK, et al. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. Pharmazie 2001;56(3):223-226
171. Yang L, Fassihi R. Modulation of diclofenac release from a totally controlled release drug delivery system. J Control Release 1997;44:135-140
172. Acikgoz M, Kas HS, Hascelik Z, et al. Chitosan microspheres of diclofenac sodium. II: In vitro and in vivo evaluation. Pharmazie 1995;50(4):275-277
173. Chawla V, Tiwary AK, Gupta S. Characterization of polyvinylalcohol microspheres of diclofenac sodium: application of statistical design. Drug Dev Ind Pharm 2000;26(6):675-680
174. Bodek KH. Evaluation of properties microcrystalline chitosan as a drug carrier. Part 1. In vitro release of diclofenac from mictocrystalline chitosan hydrogel. Acta Pol Pharm 2000;57(6):431-440
175. Sadeghi F, Ford JL, Rubinstein MH, et al. Study of drug release from pellets coated with Surelease containing hydroxypropyl-methylcellulose. Drug Dev Ind Pharm 2001;27(5):419-430
176. Sadeghi F, Ford JL, Rajabi-Siahboomi A. The influence of drug type on the release profiles from Surelease-coated pellets. Int J Pharm 2003;254(2):123-135
177. Kumbar SG, Kulkarni AR, Aminabhavi M. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. J Microencapsul 2002;19(2):173-180
178. Satturwar PM, Mandaogade PM, Fulzele SV, et al. Synthesis and evaluation of rosin-based polymers as film coating materials. Drug Dev Ind Pharm 2002;28(4):381-387
179. Kakish HF, Tashtoush B, Ibrahim HG, et al. A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium. Eur J Pharm Biopharm 2002;54(1):75-81
180. Kramar A, Turk S, Vrecer F. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm 2003;256(1-2):43-52
181. Conforti A, Bertani S, Lussignoli S, et al. Anti-inflammatory activity of polyphosphazene-based naproxen slow-release systems. J Pharm Pharmacol 1996;48(5):468-473
182. Liso PA, Rebuelta M, San Roman J, et al. Polymeric drugs derived from ibuprofen with improved antiinflammatory profile. J Biomed Mater Res 1996;32(4):553-560
183. Gallardo A, Eguiburu JL, Fernandez Berridi MJ, et al. Preparation and in vitro release studies of ibuprofen-loaded films and microspheres made from graft copolymers of poly(L-lactic acid) on acrylic backbones. J Control Release 1998;55:171-179
184. WorldHealth Organization WHO Guidelines: Cancer Pain Relief (2nd). Geneva, Switzerland: World Health Organization; 1996
185. Rang HP, Dale MM. Drugs used to suppress inflammatory and immune reactions. In: Rang HP, Dale MM, eds. Pharmacology. 2nd ed. Edinburgh: Churchill Livingstone; 1991:281-305
186. Nikkola LViitanen PAshammakhi N. Multicomponent implant for true controlled release of diclofenac sodium. Presented at the 6th International Symposium on Frontiers in Biomedical Polymers 2005 (FBPS'05), Granada, Spain, June 16-19, 2005
187. Lee HB, Khang G, Cho JC, et al. Fentanyl-loaded PLGA microspheres for long acting anesthesia. In: Park K, Mrsny RJ, eds. Controlled Drug Delivery: Designing Technologies for the Future. Washington, DC: ACS; 2000:385-394
188. Duggan AW, North RA. Electrophysiology of opioids. Pharmacol Rev 1983;35:219-281
189. Benedetti C. Neuroanatomy and biochemistry of antinociception. In: Bonica JJ, Ventafridda V, eds. Advances in Pain Research and Therapy, Vol. 2. New York: Raven Press; 1979:31-44
190. Stein C. The control of pain in peripheral tissue by opioids. New Engl J Med 1995;332:1685-1690
191. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbard LE, eds. Goodman and Gillman's the Pharmacologic Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996:531-555
192. Salman MA, Sahin A, Onur MA, et al. Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats. Acta Anaesthesiol Scand 2003;47:1006-1012
193. Levy MH. Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain 2001;5(Suppl A):113-116
194. Chen-CHow P, Frank SG. Comparison of lidocaine release from Pluronic F-127 gels and other formulations. Acta Pharm Suec 1981;18(4):239-244
195. Bernatchez SF, Merkli A, Tabatabay C, et al. Biotolerance of a semisolid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery. J Biomed Mater Res 1993;27(5):677-681
196. Mahkam M, Allahverdipoor M. Controlled release of biomolecules from pH-sensitive network polymers prepared by radiation polymerization. J Drug Target 2004;12(3):151-156
197. Jeong B, Bae YH, Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release 2000;63(1-2):155-163
198. Dollo G, Malinovsky JM, Peron A, et al. Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits. Int J Pharm 2004;272(1-2):109-119
199. Paavola A, Tarkkila P, Xu M, et al. Controlled release gel of ibuprofen and lidocaine in epidural use-analgesia and systemic absorption in pigs. Pharm Res 1998;15(3):482-487
200. Kopacz DJ, Allen HW, Hopt K, et al. Extended local anesthesia of bupivacaine-loaded microspheres-role of dexamethasone. Anesth Analg 2001;92:S260
201. Holte K, Werner MU, Lacouture PG, et al. Dexamethasone prolongs local anesthesia after subcutaneous infiltration of bupivacaine microcapsules in human volunteers. Anesthesiology 2002;96:1331-1335
202. Kopacz DJ, Bernards CM, Allen HW, et al. A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules. Anest Analg 2003;97:124-131
203. Kopacz DJ, Lacouture PG, Wu D, et al. The dose response and effects of dexamethasone on bupivacaine microcapsules foe intercostal blockade (T9 to T11) in healthy volunteers. Anesth Analg 2003;96:576-582
204. Pedersen JL, Lillesø J, Hammer NA, et al. Bupivacaine in microcapsules prolong analgesia after subcutaneous infiltration in humans: a dose-finding study. Anesth Analg 2004;99:912-918